Since 1928, human fetal tissues and stem cells have been used worldwide to treat various
conditions. Although the transplantation of the fetal midbrain substantia nigra and …

Transplantation of hematopoietic stem cells provides a means of replacing a defective
hematopoietic system in patients with a wide range of malignant and nonmalignant …

Les tissus de foetus pourraient etre su-perieurs aux tissus de source postnatale pour
certains types de greffes, a cause de leur plus grande plasticite et de leur teneur plus elevee …

Tissue from human fetal cadavers has long been used for medical research, experimental
therapies, and various other purposes. Research within the last two decades has led to …

Fetal liver hematopoietic stem and progenitor cells (HSPCs) have been considered
appropriate for the management of aplastic anemia owing to their proliferative potential …

In this study we investigated serum neopterin levels in 73 multiple myeloma (MM) patients
(63 determinations at diagnosis, 58 in remission, and 35 at relapse), in 56 monoclonal …

In mammalian ontogeny, the liver constitutes the primary hematopoietic organ for some time.
Fetal liver cells (FLC) are rich in hematopoietic stem cells with a high proliferative potential …

41 (38 males, 3 females) patients with aplastic anemia received fetal liver infusion (FLI) from
74 abortuses with gestation periods of 8–32 (Median (M)‐16) weeks and cell dose of 0.004 …

Twenty-two of 35 patients with aplastic anaemia who received fetal liver infusion (FLI),
responded to this treatment. Detailed review of bone marrow aspirates and biopsies was …

Previously, we and others have shown that fetal liver infusion (FLI) leads to autologous
hematopoietic improvement in 40–54% of patients with aplastic anemia. However, whether …